BNT162b2 Against COVID-19-Associated Emergency Department and Urgent Care Visits Among Children 5-11 Years of Age: A Test Negative Design.
Autor: | Tartof SY; Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, California, USA.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA., Frankland TB; Kaiser Permanente Hawaii Center for Integrated Health Care Research, Honolulu, Hawaii, USA., Puzniak L; Pfizer Inc., Collegeville, Pennsylvania, USA., Slezak JM; Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, California, USA., Hong V; Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, California, USA., Takhar H; Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, California, USA., Ogun OA; Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, California, USA., Simmons S; Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, California, USA., Xie F; Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, California, USA., Zamparo J; Pfizer Inc., Collegeville, Pennsylvania, USA., Ackerson BK; Southern California Permanente Medical Group, Harbor City, California, USA., Jodar L; Pfizer Inc., Collegeville, Pennsylvania, USA., McLaughlin JM; Pfizer Inc., Collegeville, Pennsylvania, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2023 Apr 18; Vol. 12 (3), pp. 177-179. |
DOI: | 10.1093/jpids/piad005 |
Abstrakt: | In a 1:1 matched test-negative design among 5- to 11-year-olds in the Kaiser Permanente Southern California health system (n = 3984), BNT162b2 effectiveness against the omicron-related emergency department or urgent care encounters was 60% [95%CI: 47-69] <3 months post-dose-two and 28% [8-43] after ≥3 months. A booster improved protection to 77% [53-88]. (© The Author(s) 2023. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |